LUNG CANCER

May 05 2026HEALTH

Does a lung cancer drug lower or raise other health risks?

Researchers tracked how often a drug called bevacizumab improved survival without causing new lung damage in people fighting the most common type of lung cancer that starts outside the lungs. The study looked at adults who had never been treated for this cancer but were about to start a standard fir

reading time less than a minute
May 04 2026SCIENCE

The Real‑World Effectiveness of Aumolertinib for Rare EGFR Mutations in Lung Cancer

Aumolertinib, a newer drug that targets the epidermal growth factor receptor (EGFR), has been tested in two hospitals on patients with a rare form of lung cancer. The cancer cells carry uncommon deletions in exon 19 of the EGFR gene, a pattern that often makes standard treatments less reliable. R

reading time less than a minute
Mar 25 2026HEALTH

Childhood Hardships and Lung Cancer Risk

Many adults are now being studied to see how tough times in childhood affect their health later. Researchers followed more than 150, 000 people from the UK Biobank for about four decades. They asked each person about scary or difficult events before age 18 and grouped them into none, mild (1–2

reading time less than a minute
Mar 06 2026HEALTH

Lung Cancer Care Shows Racial Gaps That Haven’t Closed

Recent research on Medicare patients with early‑stage lung cancer reveals a troubling trend: Black individuals are still far less likely to receive surgery or radiation that can cure the disease than their white counterparts. The study, which looked at more than 28, 000 cases from 2005 to 2019, foun

reading time less than a minute
Feb 12 2026SCIENCE

Lung Cancer Organoids: A New Lens on Precision Medicine

These tiny 3‑D cultures, called organoids, are changing how scientists study lung cancer. Instead of flat cell sheets or animal models that take months to grow, organoids can be produced quickly while keeping the original tumor’s structure and variety. Researchers now grow lung cancer organoid

reading time less than a minute
Feb 12 2026HEALTH

How Tech is Helping Lung Cancer Patients Take Control

Lung cancer patients now have a new ally in their fight against the disease. The ALIBIRD mHealth platform is a digital health tool designed to help patients manage their symptoms and improve their overall well-being. This platform is part of a growing trend in mobile health (mHealth), which aims to

reading time less than a minute
Jan 28 2026HEALTH

Decoding Lung Cancer: The Promise and Pitfalls of RNA Sequencing

Lung cancer is a major health issue, with many different types. RNA sequencing is a method used to study genes in cancer cells. It can identify fusion genes, which are mixed-up genes that can fuel cancer growth. This helps doctors choose the right treatment for each patient. In China, experts have

reading time less than a minute
Jan 22 2026HEALTH

Harmless Cancers: The Hidden Clues for New Treatments

Cancer is often seen as a relentless foe. But what if some cancers are not so aggressive? What if they can be controlled by the body's own defenses? This idea is not just a theory. It is being explored in a new way. Scientists have noticed that some cancers do not grow or spread. They stay in the b

reading time less than a minute
Jan 04 2026CELEBRITIES

Barry Manilow's Bright Side After Cancer News

Barry Manilow, the legendary singer behind "Copacabana, " has shared a hopeful update with fans just two weeks after revealing his lung cancer diagnosis. He posted a selfie on Instagram, lying in a hospital bed, wearing a gown, and sporting a big smile. The photo had a text overlay that simply said,

reading time less than a minute
Dec 22 2025CELEBRITIES

Barry Manilow Takes a Break: Cancer Diagnosis and Concert Rescheduling

Barry Manilow, the legendary singer behind classics like "Copacabana, " recently shared some news with his fans. He has been diagnosed with lung cancer. This came after a long battle with bronchitis. Doctors found a small cancerous spot on his lung during an MRI scan. The good news is that it was ca

reading time less than a minute